Tiffany N. Tanaka, MD, is a board-certified hematologist specializing in the diagnosis and treatment of blood cancers and blood disorders, with an emphasis on myeloid malignancies.
Dr. Tanaka is a translational researcher who focuses on the development of early phase trials that offer new cancer treatments for patients. Her research work includes the study of epigenetic and genetic biomarkers in myelodysplastic syndromes (bone marrow disorders in which the bone marrow does not produce enough healthy blood cells), with the aim of translating these into clinical therapies to improve patient care. Dr. Tanaka is a member of the American Society of Hematology, where she has presented her research work.
Dr. Tanaka will provide an overview of the diagnostic and treatment considerations for patients who have aplastic anemia and hypoplastic MDS. This overlapping set of bone marrow failure diseases raises critical questions for patients and health care professionals. Participants will be able to ask questions during the live webinar via the text chat window.
Thank you for registering for "Aplastic Anemia and Hypoplastic MDS: A Diagnostic and Treatment Dilemma", August 26, 2020 at 3pm EDT.
You will receive an email with a registration confirmation including the webinar link
and a call-in phone # for those participating via telephone. If you do not receive the link,
please check your Spam/Junk folders.
If you have not received a registration confirmation, please email email@example.com
or call (800) 747-2820 x2 no later than 30 minutes before the webinar is scheduled to begin.
If you are not able to join the webinar, an archived video will be available in 2 - 3 business days on the AAMDSIF website.